While Sideroflexin 3 (SFXN3) consistently displays elevated expression in head and neck squamous cell carcinoma (HNSCC), its specific pathobiological functions and prognostic value remain insufficiently characterized. The gene discussed is SFXN3; the disease is head and neck squamous cell carcinoma.